Mastrapasqua Asset Management Inc Vertex Pharmaceuticals Inc Transaction History

Mastrapasqua Asset Management Inc

$853 Million
Q3 2023

A detailed history of Mastrapasqua Asset Management Inc transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Mastrapasqua Asset Management Inc holds 7,743 shares of VRTX stock, worth $3.65 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares

7,743

Previous 7,893 1.9%

Holding current value

$3.65 Million

Previous $2.78 Million 3.06%

% of portfolio

0.32%

Previous 0.31%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 25, 2023	SELL	$338.18 - $362.46 $50,727 - $54,369	-150 Reduced 1.9%	7,743 $2.69 Million
Q2 2023 Aug 02, 2023	SELL	$314.42 - $351.91 $8,803 - $9,853	-28 Reduced 0.35%	7,893 $2.78 Million
Q1 2023 Apr 27, 2023	BUY	$283.23 - $323.1 $98,564 - $112,438	348 Added 4.6%	7,921 $2.5 Million
Q4 2022 Feb 01, 2023	BUY	$285.76 - $321.48 $221,749 - $249,468	776 Added 11.42%	7,573 $2.19 Million
Q3 2022 Oct 27, 2022	BUY	$273.83 - $305.53 $365,563 - $407,882	1,335 Added 24.44%	6,797 $1.97 Million
Q2 2022 Jul 26, 2022	BUY	$234.96 - $292.55 $88,344 - $109,998	376 Added 7.39%	5,462 $1.54 Million
Q1 2022 Apr 21, 2022	BUY	$221.42 - $260.97 $1.13 Million - $1.33 Million	5,086 New	5,086 $1.33 Million
Q4 2021 Jan 21, 2022	SELL	$177.01 - $223.45 $1.8 Million - $2.28 Million	-10,184 Closed	0 $0
Q3 2021 Nov 01, 2021	SELL	$181.39 - $202.99 $8,706 - $9,743	-48 Reduced 0.47%	10,184 $1.85 Million
Q2 2021 Aug 06, 2021	BUY	$187.49 - $221.1 $17,061 - $20,120	91 Added 0.9%	10,232 $2.06 Million
Q1 2021 May 03, 2021	BUY	$207.02 - $241.31 $156,300 - $182,189	755 Added 8.04%	10,141 $2.18 Million
Q4 2020 Feb 02, 2021	SELL	$207.01 - $276.09 $9,522 - $12,700	-46 Reduced 0.49%	9,386 $2.22 Million
Q3 2020 Nov 12, 2020	SELL	$255.65 - $303.1 $22,752 - $26,975	-89 Reduced 0.93%	9,432 $2.57 Million
Q2 2020 Jul 29, 2020	BUY	$225.48 - $295.8 $148,816 - $195,228	660 Added 7.45%	9,521 $2.76 Million
Q1 2020 May 08, 2020	BUY	$199.77 - $247.81 $164,011 - $203,452	821 Added 10.21%	8,861 $2.11 Million
Q4 2019 Feb 05, 2020	BUY	$166.71 - $223.91 $1.34 Million - $1.8 Million	8,040 New	8,040 $1.76 Million

Others Institutions Holding VRTX

# of Institutions

1,718

Shares Held

226M

Call Options Held

1.21M

Put Options Held

1.56M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $121B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mastrapasqua Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Mastrapasqua Asset Management Inc with notifications on news.

Account

Mastrapasqua Asset Management Inc Vertex Pharmaceuticals Inc Transaction History